ImmunAbs Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase 1b/2 Study of IM-101 in Adult Participants With Generalized Myasthenia Gravis and Ocular Myasthenia Gravis (NCT07250750) | ImmunAbs Inc. | 2026-02-05 |
Track ImmunAbs Inc. automatically
Every clearance here is in the API, with alerts when new ones post.